Fireside Chat with Dr. David Mack

Tuesday, June 2nd, 2:00 – 3:00 PM CST
(On Campus)

Join myCHOICE for a conversation with David Mack that spotlights his role as a leader in science and technology. Designed to offer a holistic view of a given field, Fireside Chats help you explore different career pathways and reflect on how to shape a fulfilling career of your own.

About The Speaker

Dr. David Mack

David Mack PhD ’92 Biological Sciences Division,  Co-Founder, President and CEO of PMV Pharma.

Prior to co-founding PMV Pharma with biologists Arnold Levine and Thomas Shenk, Dr. Mack was a general partner at Alta Partners from 2002 to 2013. His first investment was Angiosyn (acquired by Pfizer in 2005) where he was a director and CEO. 
Prior to Alta, Dr. Mack co-founded and served as Vice President of Genomics Research at Eos Biotechnology (acquired by Protein Design Labs in 2003).

From 1994 to 1997, he served at Affymetrix as Head of Cancer Biology where he oversaw the development and application of DNA array technology in the areas of oncology and inflammation. Dr. Mack was also a pivotal member of the Polymerase Chain Reaction (PCR) Invention Group at Cetus (now Novartis) in the mid 1980s. Dr. Mack has co-authored more than 30 scientific articles and reviews, including papers published in Cell, Science, and Nature, and is an inventor on 26 issued US patents. Dr. Mack was an American Cancer Society Postdoctoral Fellow in Microbiology and Immunology at Stanford University School of Medicine. He received his Ph.D. from the University of Chicago, where he was a Howard Hughes Fellow in Molecular Genetics and Cell Biology, and he received a B.A. in Molecular Biology from the University of California, Berkeley.

Dr. Mack has served on the Board of Directors of numerous biotechnology companies including Angiosyn, Aerie Pharmaceuticals (NASDAQ: AERI), Ceregene, Proacta Therapeutics, aTyr Pharmaceuticals (NASDAQ:LIFE), Pathwork Diagnostics, Silence Therapeutics (LON:SLN), Aduro Biotech (NASDAQ:ADRO), and Sutro Biopharma (NASDAQ:STRO). He currently serves on the Polsky Center Council for Entrepreneurship and Innovation, University of Chicago. He enjoys mentoring students and has also been an active volunteer for UChicagoGRAD and myCHOICE.